Kellerhals Carrard advises Moderna Switzerland on Covid-19 vaccination

Kellerhals Carrard, under the responsibility of partners Claudia Götz Staehelin (pictured), Oliver M. Brupbacher and Nicolas Mosimann, advised Moderna on legal and regulatory aspects related to the establishment of its supply chain for its COVID-19 Vaccine and Swiss launch preparations, including trade compliance and regulatory aspects.

Moderna is pioneering a new class of drugs, the messenger RNA Therapeutics (mRNAs), with the potential to treat a wide range of diseases and conditions. Moderna developed a vaccine against Covid-19 for which Swissmedic granted a temporary marketing authorization on 12 January 2021 under the name „COVID-19 Vaccine Moderna“ following the scientific assessment of Swissmedic.

Kellerhals Carrard advises Moderna Switzerland on Covid-19 vaccination


Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram